#London #UK #Brain-Computer Interface #MintNeuro #Neural Devices

MintNeuro Secures $5 Million to Scale Chip Technology for Neural Devices

In an impressive move for the neurotechnology sector, MintNeuro has announced a $5 million funding round aimed at scaling its purpose-designed chip platform for neural devices and brain-computer interfaces (BCIs). This investment signals a significant step forward for the semiconductor company, which specializes in creating chips that cater specifically to the unique demands of neural applications, including both implantables and wearables.

With strong backing from investors such as Odyssey Ventures, 33East, JSK Investments, and Alumni Ventures, this funding aims to accelerate MintNeuro's product launches and enhance its international presence. The firm's chips are engineered to deliver superior performance compared to off-the-shelf options, making them a more appealing choice for developers looking to implement cutting-edge neural technology without the need for prolonged and costly custom chip development.

Dorian Haci, Co-Founder and CEO of MintNeuro, expressed excitement about the funding, stating that it propels the company from the technology validation phase to a commercial scaling phase. "Every neural device relies on the chips within it, and we are committed to ending the compromise between generic components and custom development timelines. This investment is pivotal for our growth trajectory, enabling us to expedite product availability to a broader audience," he said.

MintNeuro's unique modular architecture positions it strategically to support developments across a range of neural technologies. These technologies span effects on mental health, epilepsy, Parkinson's disease, and beyond, facilitating treatments through BCIs, neuromodulation systems, and bioelectronic medicines. The company aims to eliminate the traditional barriers within the industry—the lack of customized chips that can meet the specific requirements for power, size, safety, and signal quality.

Currently, the industry has been constrained by generic semiconductor solutions that often fail to meet the critical needs of neural devices. MintNeuro, however, is closing this crucial gap with its specialized architecture, which includes capabilities for neural sensing, signal processing, and precise stimulation. These advancements allow developers to create smaller, more effective devices while significantly reducing their time to market.

The deployment of this technology is underlined by recent partnerships with various research and development teams, including collaborations with established firms such as Motif Neurotech. MintNeuro has already achieved key integration milestones, demonstrating its technology's viability in real-world applications. For instance, its partnership with Motif Neurotech involves supplying chips that support the development of a minimally invasive neurostimulator aimed at treating treatment-resistant depression.

The investment will also focus on bolstering MintNeuro's engineering and commercial workforce, preparing the company to cater to the rising demand for its chips among promising neural device companies currently integrating MintNeuro's technology into their innovations.

Michelle Robson, a Founding Partner at Odyssey Ventures, commented on the investment, acknowledging the tremendous potential that neural devices hold and the critical infrastructure needs that MintNeuro is addressing. She pointed to the market's demand for specially tailored hardware that can fuel the next wave of advancements in neurotechnology, emphasizing the company's potential to become an influential player in the semiconductor industry.

As MintNeuro gears up for its next phase of growth, the company remains committed to its vision of not only advancing medical applications but also eventually serving a wider array of devices that interface with the brain and nervous system.

"Our goal is clear—we aim to establish MintNeuro as the leading semiconductor platform for the global neurotechnology market, facilitating breakthroughs in how we understand and treat neurological and mental health conditions," added Haci.

In summary, MintNeuro's fresh funding signifies an important leap towards realizing the vast potential of neurotechnology, making it an exciting company to watch as it advances the capabilities of next-generation neural devices.